Anti-MLV p30 antibody [4B2]
Be the first to review this product! Submit a review
|
(12 Publications)
Anti-MLV p30 antibody [4B2] (ab130757) is a mouse monoclonal antibody detecting MLV p30 in Western Blot.
- Over 10 publications
View Alternative Names
Gag polyprotein, Pr65gag, Core polyprotein, gag
- WB
Unknown
Western blot - Anti-MLV p30 antibody [4B2] (AB130757)
All lanes:
Western blot - Anti-MLV p30 antibody [4B2] (ab130757) at 1/1500 dilution
All lanes:
MLV p30 recombinant protein expressed in E.coli
Predicted band size: 31.56 kDa
false
Reactivity data
Product details
Anti-MLV p30 antibody [4B2] (ab130757) is a mouse monoclonal antibody and is validated for use in Western Blot (WB). What is the molecular weight of MLV p30?
Anti-MLV p30 [4B2] (ab130757) specifically detects a band for MLV p30 (UniProt: P03332) at a molecular weight of 31.56kDa.
Trusted by the scientific community
Anti-MLV p30 [4B2] (ab130757) was first used in a scientific publication in 2012 and has been cited over 10 times in peer-reviewed journals.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The production of MLV p30 orchestrates critical steps in the viral life cycle. The protein is a major part of the matrix structure essential for maintaining virus integrity. Besides giving structure p30 interacts with other proteins to help the virus replicate and spread. It is not part of a larger known multiprotein complex but its interactions support the efficiency of viral replication within the host cells.
Pathways
MLV p30 contributes specifically to the viral assembly pathway. It directly interacts with structural proteins such as Gag which is important for MLV particle maturation and release. The p30 protein also plays a role in the incorporation of the viral envelope proteins into budding virions which is part of the lifecycle pathway of MLV. These interactions ensure the proper formation and release of virus particles.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Nature 645:235-243 PubMed40634609
2025
Applications
Unspecified application
Species
Unspecified reactive species
mBio 14:e0038723 PubMed37787515
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 97:e0165022 PubMed36790205
2023
Applications
Unspecified application
Species
Unspecified reactive species
mBio 13:e0137622 PubMed35913162
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell 185:250-265.e16 PubMed35021064
2022
Applications
Unspecified application
Species
Unspecified reactive species
Antimicrobial agents and chemotherapy : PubMed33468464
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS infectious diseases : PubMed33432808
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:6013 PubMed33243994
2020
Applications
Unspecified application
Species
Unspecified reactive species
bioRxiv : the preprint server for biology : PubMed32587973
2020
Applications
Unspecified application
Species
Unspecified reactive species
Retrovirology 15:10 PubMed29357872
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com